Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (191-200 of 526) with videos related to

Pageof 53
Sort By:
Clinical Neuropathology|August 25, 2020
Analysis of the inflammatory tumor microenvironment in meningeal neoplasmsAnna Sophie Berghoff, Philip Kresl, Orsolya Rajky, et al.
Wiener Klinische Wochenschrift|August 2, 2023
Correction to: Screening for colorectal cancerGerald Gartlehner, Eva Schernhammer, Sigurd F Lax, et al.
Wiener Klinische Wochenschrift|August 19, 2021
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology centerJulia M Berger, Margaretha Gansterer, Wolfgang Trutschnig, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Clinical & Experimental Metastasis|May 23, 2023
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancerLadislaia Wolff, Ariane Steindl, Petar Popov, et al.
Neuro-Oncology Practice|November 18, 2024
Chairing scientific sessions at international neuro-oncology meetings: An EANO guide for early-career professionalsJan-Michael Werner, George E D Petrescu, Florien Boele, et al.
Neuro-Oncology|July 28, 2025
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomasSebastien Perreault, Marjolein Geurts, Jasia Mahdi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2026
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastomaEmilie Le Rhun, Debaleena Sain, Martin van den Bent, et al.
Cancer|May 25, 2006
Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMatthias Preusser, Harald Heinzl, Ellen Gelpi, et al.
Histopathology|May 10, 2018
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcomeSven Schneider, Lorenz Kadletz, Robert Wiebringhaus, et al.
Pageof 53

Showing results (191-200 of 526) with videos related to

Sort By:
Pageof 53
Clinical Neuropathology|August 25, 2020
Analysis of the inflammatory tumor microenvironment in meningeal neoplasmsAnna Sophie Berghoff, Philip Kresl, Orsolya Rajky, et al.
Wiener Klinische Wochenschrift|August 2, 2023
Correction to: Screening for colorectal cancerGerald Gartlehner, Eva Schernhammer, Sigurd F Lax, et al.
Wiener Klinische Wochenschrift|August 19, 2021
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology centerJulia M Berger, Margaretha Gansterer, Wolfgang Trutschnig, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Clinical & Experimental Metastasis|May 23, 2023
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancerLadislaia Wolff, Ariane Steindl, Petar Popov, et al.
Neuro-Oncology Practice|November 18, 2024
Chairing scientific sessions at international neuro-oncology meetings: An EANO guide for early-career professionalsJan-Michael Werner, George E D Petrescu, Florien Boele, et al.
Neuro-Oncology|July 28, 2025
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomasSebastien Perreault, Marjolein Geurts, Jasia Mahdi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2026
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastomaEmilie Le Rhun, Debaleena Sain, Martin van den Bent, et al.
Cancer|May 25, 2006
Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMatthias Preusser, Harald Heinzl, Ellen Gelpi, et al.
Histopathology|May 10, 2018
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcomeSven Schneider, Lorenz Kadletz, Robert Wiebringhaus, et al.
Pageof 53